Clinical Trial Update: Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial update for administering Exparel during hip hemiarthroplasty in intracapsular femur/femoral neck fractures completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Neck Fracture
• Hip Hemiarthroplasty
• Intracapsular Fracture of Femur

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Intracapsular Fracture of Femur, Femoral Neck Fractures | Phase 4 | Status: COMPLETED | Results posted: 2023-11-18